Last chance to receive compensation despite new cases

"Last chance to receive compensation despite the new cases"

"For those affected by narcolepsy as a side effect of Pandemrix-the sprayer 2009 this year last chance to apply for compensation, despite the fact that patients are still diagnosed, the type SR Vetenskapsradion."

"According to Ann-Marie Landtblom, a professor of neurology at Uppsala university, it is because the patients do not always receive the right diagnosis from the beginning."

" It is important to understand that the diagnosis can sometimes be very difficult. We have seen patients who became ill after the vaccination but who have been given other, incorrect diagnoses. The last few years, I have had eight patients who fell ill in 2009-2010, but only now got his correct diagnosis and treatment, " she says to Vetenskapsradion."

"It can be about patients who had been diagnosed with anemia, or this disease because the symptoms are initially not been so clear. Another problem, says Ann-Marie Landtblom, is that the understanding of narcolepsy is not always so strong in all parts of the world."

" It is not at all rare with a very long delay of the diagnosis. So I believe that you ought to consider to extend this window for the assessment, " she says to Vetenskapsradion."

"Despite the fact that narcolepsy is svårdiagnosticerad and it may take time before you get the right care, there are no plans to extend the border to seek reimbursement, that is for all läkemedelsskador going on ten years," says Anders Hultman, skadechef and vice president at covered by pharmaceutical insurance to Vetenskapsradion."

"Narcolepsy is a neurological disorder that disrupts the brain's regulation of sleep and wakefulness. The who have narcolepsy are sleepy in the daytime and often get attacks of muscle weakness associated with different emotional states. Narcolepsy is not possible to cure but there are drug that raises alertness and improves sleep."

"the Money to the narkolepsidrabbade is paid via the covered by pharmaceutical insurance and partly by the state. The compensation is limited to a maximum of ten million kronor per person. It made an individual assessment of how much each should get."

"Source: FASS, Kammarkollegiet"